These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 22532598)
1. Inhibition of ATR-dependent signaling by protoapigenone and its derivative sensitizes cancer cells to interstrand cross-link-generating agents in vitro and in vivo. Wang HC; Lee AY; Chou WC; Wu CC; Tseng CN; Liu KY; Lin WL; Chang FR; Chuang DW; Hunyadi A; Wu YC Mol Cancer Ther; 2012 Jul; 11(7):1443-53. PubMed ID: 22532598 [TBL] [Abstract][Full Text] [Related]
2. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. Pabla N; Huang S; Mi QS; Daniel R; Dong Z J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465 [TBL] [Abstract][Full Text] [Related]
3. A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species. Chen HM; Chang FR; Hsieh YC; Cheng YJ; Hsieh KC; Tsai LM; Lin AS; Wu YC; Yuan SS Free Radic Biol Med; 2011 May; 50(9):1151-62. PubMed ID: 21256211 [TBL] [Abstract][Full Text] [Related]
4. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage. Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061 [TBL] [Abstract][Full Text] [Related]
5. DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system. Caporali S; Falcinelli S; Starace G; Russo MT; Bonmassar E; Jiricny J; D'Atri S Mol Pharmacol; 2004 Sep; 66(3):478-91. PubMed ID: 15322239 [TBL] [Abstract][Full Text] [Related]
6. Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair. Pedram A; Razandi M; Evinger AJ; Lee E; Levin ER Mol Biol Cell; 2009 Jul; 20(14):3374-89. PubMed ID: 19477925 [TBL] [Abstract][Full Text] [Related]
7. Bifunctional DNA alkylator 1,3-bis(2-chloroethyl)-1-nitrosourea activates the ATR-Chk1 pathway independently of the mismatch repair pathway. Cui B; Johnson SP; Bullock N; Ali-Osman F; Bigner DD; Friedman HS Mol Pharmacol; 2009 Jun; 75(6):1356-63. PubMed ID: 19261750 [TBL] [Abstract][Full Text] [Related]
9. p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Reinhardt HC; Aslanian AS; Lees JA; Yaffe MB Cancer Cell; 2007 Feb; 11(2):175-89. PubMed ID: 17292828 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956 [TBL] [Abstract][Full Text] [Related]
11. Decarbamoyl mitomycin C (DMC) activates p53-independent ataxia telangiectasia and rad3 related protein (ATR) chromatin eviction. Xiao G; Kue P; Bhosle R; Bargonetti J Cell Cycle; 2015; 14(5):744-54. PubMed ID: 25565400 [TBL] [Abstract][Full Text] [Related]
12. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Smith J; Tho LM; Xu N; Gillespie DA Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966 [TBL] [Abstract][Full Text] [Related]
15. Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation. Fokas E; Prevo R; Pollard JR; Reaper PM; Charlton PA; Cornelissen B; Vallis KA; Hammond EM; Olcina MM; Gillies McKenna W; Muschel RJ; Brunner TB Cell Death Dis; 2012 Dec; 3(12):e441. PubMed ID: 23222511 [TBL] [Abstract][Full Text] [Related]
16. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Lossaint G; Besnard E; Fisher D; Piette J; Dulić V Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626 [TBL] [Abstract][Full Text] [Related]
17. Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Jacquemont C; Taniguchi T Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210 [TBL] [Abstract][Full Text] [Related]
18. NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway. Jayachandran G; Ueda K; Wang B; Roth JA; Ji L PLoS One; 2010 Aug; 5(8):e11994. PubMed ID: 20700484 [TBL] [Abstract][Full Text] [Related]
19. Involvement of the ATR- and ATM-dependent checkpoint responses in cell cycle arrest evoked by pierisin-1. Shiotani B; Kobayashi M; Watanabe M; Yamamoto K; Sugimura T; Wakabayashi K Mol Cancer Res; 2006 Feb; 4(2):125-33. PubMed ID: 16513843 [TBL] [Abstract][Full Text] [Related]
20. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway. Lee HJ; Hwang HI; Jang YJ Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]